Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2017

Open Access 01-12-2017 | Research article

Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis

Authors: Quirino Ciampi, Clara Carpeggiani, Claudio Michelassi, Bruno Villari, Eugenio Picano

Published in: BMC Cardiovascular Disorders | Issue 1/2017

Login to get access

Abstract

Background

The presence of left ventricular contractile reserve (LVCR) during stress echo (SE) may provide favorable response to cardiac resynchronization therapy (CRT) in heart failure patients. The aim of the study was to perform a meta-analysis of available SE data in this set of patients.

Methods

From a Pubmed and Advance Google Scholar database web based search scan up to December 2016, we initially identified 5906 records. From this initial set, we removed that did not include SE and duplicate studies. We assessed for eligibility 71 full-text articles assessed for eligibility, and 60 of them did not meet the inclusion criteria as follow: 1) heart failure patients with NYHA class III and IV, depressed ejection fraction (EF <35%) and QRS duration ≥120 ms at study entry; 2) SE with assessment of LVCR; 3) Follow-up data. LVCR during SE was identified as reduction in wall motion score index and/or an increase in EF.

Results

Eleven studies with 861 patients (mean age 67 ± 9 years, ejection fraction 25 ± 6%) were included in the meta-analysis. The type of stress was either exercise (n = 2) or dobutamine (n = 9), the latter with low-dose (10 mcg) in two, intermediate-dose (20 mcg) in five, and high-dose (40 mcg) protocol in two studies. LVCR was detected in 555 patients (63%) and CRT-response was present in 584 (66%). The overall odds ratio for LVCR to predict a favorable CRT response was 2.06 (95%, CI 1.70–2-43), Z score: 11.055, p < 0.001.

Conclusion

The presence of LVCR during SE with either dobutamine or exercise is associated with a greater chance of response to CRT. This parameter is now ready to be tested in a prospective multicenter trial to select patients more likely to benefit from CRT.
Literature
1.
go back to reference Askenazi J, Alexander JH, Koenigsberg DI, Belic N, Lesch M. Alteration of left ventricular performance by left bundle branch block simulated with atrioventricular sequential pacing. Am J Cardiol. 1984;53:99–104.CrossRefPubMed Askenazi J, Alexander JH, Koenigsberg DI, Belic N, Lesch M. Alteration of left ventricular performance by left bundle branch block simulated with atrioventricular sequential pacing. Am J Cardiol. 1984;53:99–104.CrossRefPubMed
2.
go back to reference Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100:999–1008.CrossRefPubMed Mann DL. Mechanisms and models in heart failure: a combinatorial approach. Circulation. 1999;100:999–1008.CrossRefPubMed
3.
go back to reference Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am CollCardiol. 1999;33:734–42.CrossRef Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am CollCardiol. 1999;33:734–42.CrossRef
4.
go back to reference Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRefPubMed Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.CrossRefPubMed
5.
go back to reference Picano E, Pellikka PA. Stress echo applications beyond coronary artery disease. Eur Heart J. 2014;35:1033–40.CrossRefPubMed Picano E, Pellikka PA. Stress echo applications beyond coronary artery disease. Eur Heart J. 2014;35:1033–40.CrossRefPubMed
6.
go back to reference Lancellotti P, Pellikka PA, Budts W, Chaudry Donal E, Dulgheru R, et al. Recommendations for the clinical use of stress echocardiography in non-ischemic heart disease: joint document of the European Association of Cardiovascular imaging and the American Society of Echocardiography. Eur Heart J Cardiov Imaging. 2016;190:1191–229.CrossRef Lancellotti P, Pellikka PA, Budts W, Chaudry Donal E, Dulgheru R, et al. Recommendations for the clinical use of stress echocardiography in non-ischemic heart disease: joint document of the European Association of Cardiovascular imaging and the American Society of Echocardiography. Eur Heart J Cardiov Imaging. 2016;190:1191–229.CrossRef
7.
go back to reference Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–94.CrossRefPubMed Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65–94.CrossRefPubMed
8.
go back to reference Da Costa A, Thévenin J, Roche F, Faure E, Roméyer-Bouchard C, Messier M, et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3:406–13. Da Costa A, Thévenin J, Roche F, Faure E, Roméyer-Bouchard C, Messier M, et al. Prospective validation of stress echocardiography as an identifier of cardiac resynchronization therapy responders. Heart Rhythm. 2006;3:406–13.
9.
go back to reference RocchiG BM, Biffi M, Ziacchi M, Biagini E, Gallelli I, et al. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. Eur Heart J. 2009;30:89–97.CrossRef RocchiG BM, Biffi M, Ziacchi M, Biagini E, Gallelli I, et al. Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. Eur Heart J. 2009;30:89–97.CrossRef
10.
go back to reference Ciampi Q, Pratali L, Citro R, Piacenti M, Villari B, Picano E. Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echo. Eur J Heart Fail. 2009;11:489–96.CrossRefPubMed Ciampi Q, Pratali L, Citro R, Piacenti M, Villari B, Picano E. Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echo. Eur J Heart Fail. 2009;11:489–96.CrossRefPubMed
11.
go back to reference Lancellotti P, Senechal M, Moonen M, Donal E, Magne J, Nellessen E, et al. Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling aftercardiac resynchronization therapy. Eur J Echocardiogr. 2009;10:663–8.CrossRefPubMed Lancellotti P, Senechal M, Moonen M, Donal E, Magne J, Nellessen E, et al. Myocardial contractile reserve during exercise predicts left ventricular reverse remodelling aftercardiac resynchronization therapy. Eur J Echocardiogr. 2009;10:663–8.CrossRefPubMed
12.
go back to reference Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Blier L, et al. Contractile reserve assessed using dobutamine echocardiography predicts left ventricular reverse remodelingafter cardiac resynchronization therapy: prospective validation in patients with left ventricular dyssynchrony. Echocardiography. 2010;27:668–76.CrossRefPubMed Sénéchal M, Lancellotti P, Magne J, Garceau P, Champagne J, Blier L, et al. Contractile reserve assessed using dobutamine echocardiography predicts left ventricular reverse remodelingafter cardiac resynchronization therapy: prospective validation in patients with left ventricular dyssynchrony. Echocardiography. 2010;27:668–76.CrossRefPubMed
13.
go back to reference Chaudhry FA, Shah A, Bangalore S, DeRose J, Steinberg JS. Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle. J Am SocEchocardiogr. 2011;24:91–7.CrossRef Chaudhry FA, Shah A, Bangalore S, DeRose J, Steinberg JS. Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle. J Am SocEchocardiogr. 2011;24:91–7.CrossRef
14.
go back to reference Altman RK, McCarty D, Chen-Tournoux AA, Tournoux FB, Riedl L, Orencole M, et al. Usefulness of low dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy. Am J Cardiol. 2011;108:252–7.CrossRefPubMed Altman RK, McCarty D, Chen-Tournoux AA, Tournoux FB, Riedl L, Orencole M, et al. Usefulness of low dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy. Am J Cardiol. 2011;108:252–7.CrossRefPubMed
15.
go back to reference Gasparini M, Muto C, Iacopino S, Zanon F, Dicandia C, Distefano G, et al. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identifycardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in cardiac resynchronization therapy (LODO-CRT) phase 2 study. Am Heart J. 2012;163:422–9.CrossRefPubMed Gasparini M, Muto C, Iacopino S, Zanon F, Dicandia C, Distefano G, et al. Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identifycardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in cardiac resynchronization therapy (LODO-CRT) phase 2 study. Am Heart J. 2012;163:422–9.CrossRefPubMed
16.
go back to reference Pugliese M, Minardi G, Vitali A, Natale E, De Girolamo P, Zampi G, et al. Influence of myocardial viability on responsiveness to cardiac resynchronization in ischemic dilated cardiomyopathy: a prospective observational cohort study. AnadoluKardiyolDerg. 2012;12:132–41. Pugliese M, Minardi G, Vitali A, Natale E, De Girolamo P, Zampi G, et al. Influence of myocardial viability on responsiveness to cardiac resynchronization in ischemic dilated cardiomyopathy: a prospective observational cohort study. AnadoluKardiyolDerg. 2012;12:132–41.
17.
go back to reference Mizia-Stec K, Wita K, Mizia M, Szwed H, Nowalany-Kozielska E, Chrzanowski L, et al. Preserved contractile reserve in a dobutamine test for the prediction of a response to resynchronisation therapy in ischaemic and non-ischaemic cardiomyopathy - a multicenterViaCRTstudy. Int J Cardiol. 2014;172:476–7.CrossRefPubMed Mizia-Stec K, Wita K, Mizia M, Szwed H, Nowalany-Kozielska E, Chrzanowski L, et al. Preserved contractile reserve in a dobutamine test for the prediction of a response to resynchronisation therapy in ischaemic and non-ischaemic cardiomyopathy - a multicenterViaCRTstudy. Int J Cardiol. 2014;172:476–7.CrossRefPubMed
18.
go back to reference Murín P, Mitro P, Valocik G, Spurný P. Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy. Echocardiography. 2015;32:490–5.CrossRefPubMed Murín P, Mitro P, Valocik G, Spurný P. Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy. Echocardiography. 2015;32:490–5.CrossRefPubMed
20.
go back to reference Sutton AJ, Abrams KR, Jones DR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research, vol. 1. Chichester: Wiley; 2000. Sutton AJ, Abrams KR, Jones DR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research, vol. 1. Chichester: Wiley; 2000.
21.
23.
go back to reference Kloosterman M, Damman K, Van Veldhuisen DJ, Rienstra M, Maass AH. The importance of myocardial contractile reserve in predicting response to cardiac resynchronization therapy. Eur J Heart Fail. 2017;24 doi:10.1002/ejhf.768. [Epub ahead of print] Kloosterman M, Damman K, Van Veldhuisen DJ, Rienstra M, Maass AH. The importance of myocardial contractile reserve in predicting response to cardiac resynchronization therapy. Eur J Heart Fail. 2017;24 doi:10.​1002/​ejhf.​768. [Epub ahead of print]
24.
go back to reference Picano E, Marzullo P, Gigli G, Reisenhofer B, Parodi O, Distante A, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol. 1992;70:703–10.CrossRefPubMed Picano E, Marzullo P, Gigli G, Reisenhofer B, Parodi O, Distante A, et al. Identification of viable myocardium by dipyridamole-induced improvement in regional left ventricular function assessed by echocardiography in myocardial infarction and comparison with thallium scintigraphy at rest. Am J Cardiol. 1992;70:703–10.CrossRefPubMed
25.
go back to reference Sicari R, Pingitore A, Aquaro G, Pasanisi EM, Lombardi M, Picano E. Cardiac functional stress imaging: a sequential approach with stress echo and cardiovascular magnetic resonance. Cardiovasc Ultrasound. 2007;5:47.CrossRefPubMedPubMedCentral Sicari R, Pingitore A, Aquaro G, Pasanisi EM, Lombardi M, Picano E. Cardiac functional stress imaging: a sequential approach with stress echo and cardiovascular magnetic resonance. Cardiovasc Ultrasound. 2007;5:47.CrossRefPubMedPubMedCentral
26.
go back to reference Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945–53.CrossRefPubMed Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945–53.CrossRefPubMed
27.
go back to reference Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41.CrossRefPubMed Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, Dibbets-Schneider P, et al. Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J. 2007;28:33–41.CrossRefPubMed
28.
go back to reference Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. STICH Trial Investigators.Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.CrossRefPubMedPubMedCentral Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P, et al. STICH Trial Investigators.Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011;364:1617–25.CrossRefPubMedPubMedCentral
29.
go back to reference Picano E, Ciampi Q, Citro R, D'Andrea A, Scali MC, Cortigiani L, Olivotto I, Mori F, Galderisi M, Costantino MF, Pratali L, Di Salvo G, Bossone E, Ferrara F, Gargani L, Rigo F, Gaibazzi N, Limongelli G, Pacileo G, Andreassi MG, Pinamonti B, Massa L, Torres MAR, Miglioranza MH, BorguezanDaros C, de Castro e Silva Pretto JL, Beleslin B, Djordjevic-Dikic A, Varga A, Palinkas A, Agoston G, Gregori D, Trambaiolo P, Severino S, Arystan A, Paterni M, Carpeggiani C, Colonna P, Stress echo 2020. The international stress Echo study in ischemic and non-ischemic heart disease. Cardiovasc Ultrasound. 2017;15:3. doi:10.1186/s12947-016-0092-1.CrossRefPubMedPubMedCentral Picano E, Ciampi Q, Citro R, D'Andrea A, Scali MC, Cortigiani L, Olivotto I, Mori F, Galderisi M, Costantino MF, Pratali L, Di Salvo G, Bossone E, Ferrara F, Gargani L, Rigo F, Gaibazzi N, Limongelli G, Pacileo G, Andreassi MG, Pinamonti B, Massa L, Torres MAR, Miglioranza MH, BorguezanDaros C, de Castro e Silva Pretto JL, Beleslin B, Djordjevic-Dikic A, Varga A, Palinkas A, Agoston G, Gregori D, Trambaiolo P, Severino S, Arystan A, Paterni M, Carpeggiani C, Colonna P, Stress echo 2020. The international stress Echo study in ischemic and non-ischemic heart disease. Cardiovasc Ultrasound. 2017;15:3. doi:10.​1186/​s12947-016-0092-1.CrossRefPubMedPubMedCentral
30.
go back to reference Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy. Am Heart J. 2010;160:906–14.CrossRefPubMed Ciampi Q, Pratali L, Citro R, Villari B, Picano E, Sicari R. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy. Am Heart J. 2010;160:906–14.CrossRefPubMed
31.
go back to reference Delgado-Montero A, Tayal B, Goda A, Ryo K, Marek JJ, Sugahara M, et al. Additive prognostic value of echocardiographic global longitudinal and global circumferential strain to electrocardiographic criteria in patients with heart failure undergoing cardiac resynchronization therapy. Circ Cardiovasc Imaging.. 2016;9. doi:10.1161/CIRCIMAGING.115.004241. Delgado-Montero A, Tayal B, Goda A, Ryo K, Marek JJ, Sugahara M, et al. Additive prognostic value of echocardiographic global longitudinal and global circumferential strain to electrocardiographic criteria in patients with heart failure undergoing cardiac resynchronization therapy. Circ Cardiovasc Imaging.. 2016;9. doi:10.​1161/​CIRCIMAGING.​115.​004241.
32.
go back to reference Farsalinos KE, Daraban AM, Ünlü S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr. 2015;28:1171–81.CrossRefPubMed Farsalinos KE, Daraban AM, Ünlü S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr. 2015;28:1171–81.CrossRefPubMed
33.
go back to reference Parsai C, Baltabaeva A, Anderson L, Chaparro M, Bijnens B, Sutherland GR. Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy. Eur Heart J. 2009;30:950–8.CrossRefPubMed Parsai C, Baltabaeva A, Anderson L, Chaparro M, Bijnens B, Sutherland GR. Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy. Eur Heart J. 2009;30:950–8.CrossRefPubMed
34.
go back to reference Stankovic I, Aarones M, Smith HJ, Vörös G, Kongsgaard E, Neskovic AN, et al. Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy. Eur Heart J. 2014;35:48–55.CrossRefPubMed Stankovic I, Aarones M, Smith HJ, Vörös G, Kongsgaard E, Neskovic AN, et al. Dynamic relationship of left-ventricular dyssynchrony and contractile reserve in patients undergoing cardiac resynchronization therapy. Eur Heart J. 2014;35:48–55.CrossRefPubMed
Metadata
Title
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis
Authors
Quirino Ciampi
Clara Carpeggiani
Claudio Michelassi
Bruno Villari
Eugenio Picano
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2017
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-017-0657-4

Other articles of this Issue 1/2017

BMC Cardiovascular Disorders 1/2017 Go to the issue